The cardiac toxicity of anabolic steroids

M. L. Sullivan, C. M. Martinez, P. Gennis, E. John Gallagher

Research output: Contribution to journalArticle

268 Citations (Scopus)

Abstract

Anabolic steroids are synthetic derivatives of testosterone that were developed as adjunct therapy for a variety of medical conditions. Today they are most commonly used to enhance athletic performance and muscular development. Both illicit and medically indicated anabolic steroid use have been temporally associated with many subsequent defects within each of the body systems. Testosterone is the preferred ligand of the human androgen receptor in the myocardium and directly modulates transcription, translation, and enzyme function. Consequent alterations of cellular pathology and organ physiology are similar to those seen with heart failure and cardiomyopathy. Hypertension, ventricular remodeling, myocardial ischemia, and sudden cardiac death have each been temporally and causally associated with anabolic steroid use in humans. These effects persist long after use has been discontinued and have significant impact on subsequent morbidity and mortality. The mechanisms of cardiac disease as a result of anabolic steroid use are discussed in this review.

Original languageEnglish (US)
Pages (from-to)1-15
Number of pages15
JournalProgress in Cardiovascular Diseases
Volume41
Issue number1
StatePublished - 1998

Fingerprint

Testosterone Congeners
Testosterone
Athletic Performance
Ventricular Remodeling
Muscle Development
Sudden Cardiac Death
Cardiomyopathies
Myocardial Ischemia
Heart Diseases
Myocardium
Heart Failure
Pathology
Ligands
Hypertension
Morbidity
Mortality
Cardiotoxicity
Enzymes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998). The cardiac toxicity of anabolic steroids. Progress in Cardiovascular Diseases, 41(1), 1-15.

The cardiac toxicity of anabolic steroids. / Sullivan, M. L.; Martinez, C. M.; Gennis, P.; Gallagher, E. John.

In: Progress in Cardiovascular Diseases, Vol. 41, No. 1, 1998, p. 1-15.

Research output: Contribution to journalArticle

Sullivan, ML, Martinez, CM, Gennis, P & Gallagher, EJ 1998, 'The cardiac toxicity of anabolic steroids', Progress in Cardiovascular Diseases, vol. 41, no. 1, pp. 1-15.
Sullivan, M. L. ; Martinez, C. M. ; Gennis, P. ; Gallagher, E. John. / The cardiac toxicity of anabolic steroids. In: Progress in Cardiovascular Diseases. 1998 ; Vol. 41, No. 1. pp. 1-15.
@article{1fdcdf60645f49ac8e022984f0ef5353,
title = "The cardiac toxicity of anabolic steroids",
abstract = "Anabolic steroids are synthetic derivatives of testosterone that were developed as adjunct therapy for a variety of medical conditions. Today they are most commonly used to enhance athletic performance and muscular development. Both illicit and medically indicated anabolic steroid use have been temporally associated with many subsequent defects within each of the body systems. Testosterone is the preferred ligand of the human androgen receptor in the myocardium and directly modulates transcription, translation, and enzyme function. Consequent alterations of cellular pathology and organ physiology are similar to those seen with heart failure and cardiomyopathy. Hypertension, ventricular remodeling, myocardial ischemia, and sudden cardiac death have each been temporally and causally associated with anabolic steroid use in humans. These effects persist long after use has been discontinued and have significant impact on subsequent morbidity and mortality. The mechanisms of cardiac disease as a result of anabolic steroid use are discussed in this review.",
author = "Sullivan, {M. L.} and Martinez, {C. M.} and P. Gennis and Gallagher, {E. John}",
year = "1998",
language = "English (US)",
volume = "41",
pages = "1--15",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The cardiac toxicity of anabolic steroids

AU - Sullivan, M. L.

AU - Martinez, C. M.

AU - Gennis, P.

AU - Gallagher, E. John

PY - 1998

Y1 - 1998

N2 - Anabolic steroids are synthetic derivatives of testosterone that were developed as adjunct therapy for a variety of medical conditions. Today they are most commonly used to enhance athletic performance and muscular development. Both illicit and medically indicated anabolic steroid use have been temporally associated with many subsequent defects within each of the body systems. Testosterone is the preferred ligand of the human androgen receptor in the myocardium and directly modulates transcription, translation, and enzyme function. Consequent alterations of cellular pathology and organ physiology are similar to those seen with heart failure and cardiomyopathy. Hypertension, ventricular remodeling, myocardial ischemia, and sudden cardiac death have each been temporally and causally associated with anabolic steroid use in humans. These effects persist long after use has been discontinued and have significant impact on subsequent morbidity and mortality. The mechanisms of cardiac disease as a result of anabolic steroid use are discussed in this review.

AB - Anabolic steroids are synthetic derivatives of testosterone that were developed as adjunct therapy for a variety of medical conditions. Today they are most commonly used to enhance athletic performance and muscular development. Both illicit and medically indicated anabolic steroid use have been temporally associated with many subsequent defects within each of the body systems. Testosterone is the preferred ligand of the human androgen receptor in the myocardium and directly modulates transcription, translation, and enzyme function. Consequent alterations of cellular pathology and organ physiology are similar to those seen with heart failure and cardiomyopathy. Hypertension, ventricular remodeling, myocardial ischemia, and sudden cardiac death have each been temporally and causally associated with anabolic steroid use in humans. These effects persist long after use has been discontinued and have significant impact on subsequent morbidity and mortality. The mechanisms of cardiac disease as a result of anabolic steroid use are discussed in this review.

UR - http://www.scopus.com/inward/record.url?scp=0031880293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031880293&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 1

EP - 15

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 1

ER -